Medikaloka Hermina Pt Stock Current Valuation
| HEAL Stock | IDR 1,290 10.00 0.77% |
Valuation analysis of Medikaloka Hermina helps investors to measure Medikaloka Hermina's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Medikaloka Hermina's price fluctuation is very steady at this time. Calculation of the real value of Medikaloka Hermina is based on 3 months time horizon. Increasing Medikaloka Hermina's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Medikaloka Hermina PT is useful when determining the fair value of the Medikaloka stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Medikaloka Hermina. Since Medikaloka Hermina is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Medikaloka Stock. However, Medikaloka Hermina's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1290.0 | Real 1256.06 | Hype 1290.0 | Naive 1171.76 |
The real value of Medikaloka Stock, also known as its intrinsic value, is the underlying worth of Medikaloka Hermina Company, which is reflected in its stock price. It is based on Medikaloka Hermina's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Medikaloka Hermina's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Medikaloka Hermina's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Medikaloka Hermina PT helps investors to forecast how Medikaloka stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Medikaloka Hermina more accurately as focusing exclusively on Medikaloka Hermina's fundamentals will not take into account other important factors: Medikaloka Hermina PT Company Current Valuation Analysis
Medikaloka Hermina's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medikaloka Hermina Current Valuation | 23.44 T |
Most of Medikaloka Hermina's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medikaloka Hermina PT is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medikaloka Hermina PT has a Current Valuation of 23.44 T. This is much higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Indonesia stocks is significantly lower than that of the firm.
Medikaloka Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medikaloka Hermina's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medikaloka Hermina could also be used in its relative valuation, which is a method of valuing Medikaloka Hermina by comparing valuation metrics of similar companies.Medikaloka Hermina is currently under evaluation in current valuation category among related companies.
Medikaloka Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0704 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 23.44 T | |||
| Shares Outstanding | 14.48 B | |||
| Shares Owned By Insiders | 51.07 % | |||
| Shares Owned By Institutions | 7.10 % | |||
| Price To Earning | 7.42 X | |||
| Price To Book | 6.72 X | |||
| Price To Sales | 4.66 X | |||
| Revenue | 5.82 T | |||
| Gross Profit | 2.71 T | |||
| EBITDA | 1.9 T | |||
| Net Income | 1 T | |||
| Cash And Equivalents | 590.19 B | |||
| Cash Per Share | 40.20 X | |||
| Total Debt | 1.47 T | |||
| Debt To Equity | 0.41 % | |||
| Current Ratio | 1.59 X | |||
| Book Value Per Share | 230.87 X | |||
| Cash Flow From Operations | 1.86 T | |||
| Earnings Per Share | 32.62 X | |||
| Target Price | 1693.1 | |||
| Number Of Employees | 14.38 K | |||
| Beta | 0.4 | |||
| Market Capitalization | 22.15 T | |||
| Total Asset | 7.59 T | |||
| Z Score | 9.0 | |||
| Annual Yield | 0 % | |||
| Net Asset | 7.59 T | |||
| Last Dividend Paid | 6.0 |
About Medikaloka Hermina Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medikaloka Hermina PT's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medikaloka Hermina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medikaloka Hermina PT based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Medikaloka Hermina using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Medikaloka Hermina PT. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Medikaloka Stock analysis
When running Medikaloka Hermina's price analysis, check to measure Medikaloka Hermina's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medikaloka Hermina is operating at the current time. Most of Medikaloka Hermina's value examination focuses on studying past and present price action to predict the probability of Medikaloka Hermina's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medikaloka Hermina's price. Additionally, you may evaluate how the addition of Medikaloka Hermina to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |